Sanofi-Synthelabo Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle recall — FDA D-886-2013
Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.